Dr. Xu Song, Founder and Chairman of LingTaiKe Bio, Confirmed to Speak at the 2023 Future Healthcare Technology Conference on lncRNA-Based Nucleic Acid Therapeutics

The latest 2023 Nature Index rankings, released recently, show that China has surpassed the United States in this ranking for the first time, underscoring the rapid advancement of China’s scientific research and fundamental research capabilities. Perhaps now and in the near future, we should venture further into the unknown, vast, and mysterious “uncharted territories,” acting as explorers, questioners, and pioneers.

The 2023 Future Healthcare Technology Conference will be held in Hefei from November 30 to December 1, 2023.The conference will systematically review the 30 most noteworthy frontier technologies in the life and health sector, inviting research scholars at the forefront of these technological trends to share their insights on future developments. It aims to create a technological feast featuring the release of cutting-edge technologies, the showcase of innovative tech products, and ecosystem collaboration among medical technology enterprises. Having been successfully held for three consecutive years, this year’s conference is expected to attract over 100 influential figures in technology, 100 tech companies, and 800 professional attendees.

Song Xu, Founder & Chairman of Lintek Biotech, Chief Scientist of the National Key R&D Program, and one of the pioneers in the lncRNA field, has confirmed his attendance at the 2023 Future Healthcare Technology Conference, and will address《lncRNAs Open Up New Frontiers in Nucleic Acid Therapeutics》》Share insights on the topic.

Mr. Xu Song, Founder & Chairman of Lingtaike Biotechnology, Chief Scientist of the National Key R&D Program, Executive Director of the Chinese Society of Genetics, Chairman of the Sichuan Society of Genetics, and one of the pioneers in the field of lncRNA.
Pioneered the international reporting of the mechanisms by which lncRNA-protein interactions contribute to tumorigenesis and tumor progression. Published numerous papers as corresponding author in journals such as Cell Research, Science Advances, NAR, and PNAS; led multiple key projects under the National Key R&D Program of the Ministry of Science and Technology, the 973 Program, and the National Science and Technology Major Project on “Major New Drug Development.”

Main Forum — Medical Technology Trendsetter Conference

Time: Nov 30–Dec 1 (2 days) 09:00–17:00

As the main forum of the 2023 Future Medical Technology Conference, the 2023 Future Medical Technology Trendsetter Summit will be divided into four segments: the Opening Ceremony, Digital Technology, Biotechnology, and Intelligent Manufacturing. Focusing on 30 major frontier technology trends, the event will invite relevant government officials, academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, leading scholars in frontier technologies, corporate representatives, and renowned investors to participate.

Thematic Forum — Smart Medical Device Innovation Forum

Time: November 30, 13:30-17:00

Following the release of the 2019 Catalogue for Guiding Industrial Structure Adjustment, the development and application of high-end medical devices, such as AI-assisted medical equipment, have once again been included in the encouraged category of the 2023 catalogue. This signifies that the integrated innovation of digital technologies and medical devices has become a significant development trend in the healthcare industry. This forum specially invites research experts, entrepreneurs from the intelligent medical device sector, and investors to comprehensively interpret the development progress of intelligent medical devices from the perspectives of policy, upstream and downstream industry chains, and capital markets, and to jointly explore future trends and innovative pathways for intelligent medical devices.

Thematic Forum – Frontier Technological Innovation in Gene Sequencing

Time: November 30, 13:30-17:00

Gene sequencing is one of the most prominent innovative technologies in frontier science and clinical applications, representing a highly lucrative sector. In a remarkably short period, gene sequencing technology has fostered a vast industrial chain, with upstream segments comprising sequencers and consumables, midstream segments focused on sequencing and data services, and downstream segments dedicated to research and clinical applications. This forum will focus on discussing the development of cutting-edge gene sequencing technologies and innovations in their applications.

Thematic Forum – Generative AI Scenario Innovation Application Forum

Time: December 1, 09:00-12:00

With the explosive growth and diversification of medical data, the application of artificial intelligence in the healthcare sector has become increasingly prevalent. Over the past year, generative AI, as the most creative and imaginative branch of artificial intelligence technologies, has firmly captured the attention of healthcare professionals. This forum will invite research experts, leading AI enterprises, and top-tier investors to provide an in-depth analysis of the latest developments and applications of generative AI, as well as its future opportunities.

2023 FTC 5th Frontier Technology Forum in Cardiac Surgery

Time: December 1, 09:00-17:00

Co-hosted by the Cardiac Surgery Technology and Engineering Committee of the China Medical Biotechnology Association and Peking Union Medical College Hospital, and co-organized by VCBeat, the “2023 FTC 5th Frontier Technologies Forum in Cardiac Surgery” aims to bring together experts, scholars, corporate representatives, and industry professionals from both domestic and international cardiac surgery fields to jointly discuss technological advancements and development trends, industrial innovation, and collaborative opportunities in cardiac surgery.

The 3rd Conference of the Innovation and Translation Branch of Neurosurgery, China Association of Health Care for the Elderly

Time: December 1, 09:00-17:00

Centered on the ITMNS Association’s clinical resources, the forum will collaborate with regulatory review agencies, innovative enterprises, financial capital, and other resources for innovation translation. Through white paper releases, awards for outstanding projects, and sharing of innovative practices, it will establish a platform for in-depth exchange and win-win cooperation among experts, scholars, entrepreneurs, and other stakeholders in the field of neurosurgery, fostering dialogue on frontier trends and collaborative applications in domestic neurosurgical translational research and industrial innovation.

For more details on conference speakers, seeCountdown to the Conference | First Batch of Speakers Announced for the 2023 Future Healthcare Technology Conference。